BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2112165)

  • 1. Mupirocin: a new topical antibiotic.
    Leyden JJ
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
    Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
    Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.
    Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection.
    Rode H; de Wet PM; Millar AJ; Cywes S
    J Antimicrob Chemother; 1988 May; 21(5):589-95. PubMed ID: 3134320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical development of mupirocin.
    Pappa KA
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):873-9. PubMed ID: 2112164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Antibiotic Use Coselects for the Carriage of Mobile Genetic Elements Conferring Resistance to Unrelated Antimicrobials in Staphylococcus aureus.
    Carter GP; Schultz MB; Baines SL; Gonçalves da Silva A; Heffernan H; Tiong A; Pham PH; Monk IR; Stinear TP; Howden BP; Williamson DA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
    McLinn S
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
    Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
    Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mupirocin ointment in the treatment of secondarily infected dermatoses.
    Breneman DL
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Gisby J; Bryant J
    Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mupirocin-resistant Staphylococcus aureus.
    Cookson BD; Lacey RW; Noble WC; Reeves DS; Wise R; Redhead RJ
    Lancet; 1990 May; 335(8697):1095-6. PubMed ID: 1970392
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
    Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.
    Semret M; Miller MA
    Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
    McLinn S
    Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
    Afset JE; Maeland JA
    Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmissible mupirocin resistance in Staphylococcus aureus.
    Rahman M; Noble WC; Cookson B
    Epidemiol Infect; 1989 Apr; 102(2):261-70. PubMed ID: 2495227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of mupirocin, a new topical agent against Staphylococcus aureus].
    Rosales Rodríguez M
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):572-3. PubMed ID: 2129195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
    Baek YS; Jeon J; Ahn JW; Song HJ
    Int J Dermatol; 2016 Apr; 55(4):e191-7. PubMed ID: 26892888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.